Showing 123 results
-
Media Release /In 2020, Novartis contributed PHP 7.6 billion to the Gross Domestic Product of the Philippines. The company's business operations created a total of 9,183 local jobs, including the employment of…
-
Media Release /Filipinos living with axial spondyloarthritis (axSpA) are invited to share their unique personal insights and challenges in coping with the debilitating disease by participating in the…
-
Media Release /In observance of National Kidney Month, Novartis Healthcare Philippines, the National Kidney & Transplant Institute (NKTI), and partner patient advocacy groups are promoting awareness on the…
-
Media Release /A global research initiative assessing the impact and burden of axial spondyloarthritis (axSpA) from the patient’s perspective has revealed gaps in diagnosis, treatment and work support for people…
-
Media Release /Novartis partnered with ICanServe Foundation to develop an animated video that aims to teach Filipino women how and when to do breast self-examination (BSE) in relation to age-associated early…
-
Media Release /
Novartis provides manufacturing capabilities to support global COVID-19 vaccines, tocilizumab supply
In May 2020, AveXis, a Novartis Company entered into a manufacturing agreement with Massachusetts Eye and Ear and Massachusetts General Hospital to produce the hospital's novel genetic COVID-19… -
Media Release /Novartis Healthcare Philippines, Inc. Corporate Affairs Head, Ms. Christine Fajardo, has been elected Chairperson of the Philippine-Swiss Business Council (PSBC). The PSBC serves as a channel for…
-
Media Release /In line with the observance of World Glaucoma Week on March 7-13, 2021, Novartis Healthcare Philippines, Inc. has entered into a partnership with the Philippine Academy of Ophthalmology and…
-
Media Release /Attended by almost 600 participants across Asia Pacific from 200 patient organizations, APPIS 2021 marks the region-first Asia Pacific Patient Summit focused on building a program of multi-…
-
Media Release /In line with its commitment to bring more of its cancer medicines to more Filipino patients, Novartis voluntarily reduced the prices of a broad range of cancer medicines in its Oncology portfolio…
